CHOROIDEREMIA
Clinical trials for CHOROIDEREMIA explained in plain language.
Never miss a new study
Get alerted when new CHOROIDEREMIA trials appear
Sign up with your email to follow new studies for CHOROIDEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene Therapy's lasting effects on vision tracked in Long-Term study
Disease control CompletedThis study follows people with two inherited eye conditions—choroideremia and X-linked retinitis pigmentosa—who previously received gene therapy. Researchers monitor their safety and vision over several years to see if the treatment remains safe and helps preserve sight. Particip…
Matched conditions: CHOROIDEREMIA
Phase: PHASE3 • Sponsor: NightstaRx Ltd, a Biogen Company • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Experimental eye injection aims to restore sight in rare blindness conditions
Disease control CompletedThis study tested an experimental drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two inherited conditions that cause progressive vision loss. The main goal was to check safety and tolerability at increasing doses. …
Matched conditions: CHOROIDEREMIA
Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC